Acetyl-l-carnitine reduces the infarct size and striatal glutamate outflow following focal cerebral ischemia in rats

Annals of the New York Academy of Sciences

Volumn 1199, Issue , 2010, Pages 95-104

  Jalal, Fakhreya Yousuf ^a   Böhlke, Mark ^a   Maher, Timothy J ^a  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

ALCAR; cerebral ischemia; glutamate; infarct size; microdialysis; stroke

Indexed keywords

GLUTAMIC ACID; LEVACECARNINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFICACY; DRUG STRUCTURE; MALE; MICRODIALYSIS; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; RAT;

RATTUS;

EID: 77953992146     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05351.x     Document Type: Conference Paper

References (52)

1. Frandsen, A. & A. Schousboe. 2003. AMPA receptormediated neurotoxicity: role of Ca2+ and desensitization. Neurochem. Res. 28: 1495-1499.
2. Dirnagl,U., C. Iadecola&M.A.Moskowitz. 1999. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22: 391-397.
3. Kosugi, T. & K. Kawahara. 2006. Reversed actrocytic GLT-1 during ischemia is crucial to excitotoxic death of neurons, but contributes to the survival of astrocytes themselves. Neurochem. Res. 31: 933-943.
4. Lin, B., M.Y. Globus, W.D. Dietrich, et al. 1992. Differing neurochemical and morphological sequelae of global ischemia: comparison of single-and multipleinsult paradigms. J. Neurochem. 59: 2213-2223.
5. Ghelardini, C., N. Galeotti, M. Calvani, et al. 2002. Acetyl-L-carnitine inducesmuscarinic antinocieption in mice and rats. Neuropharmacology 43: 1180-1187.
6. Lombardo, P., R. Scuri, E. Cataldo, et al. 2004. Acetyl-Lcarnitine induces a sustained potentiation of the afterhyperpolarization. Neuroscience 128: 293-303.
7. De Falco, F.A., E. D'Angelo, G. Grimaldi, et al. 1994. Effect of the chronic treatment with L-acetylcarnitine in Down's syndrome. Clin. Ter. 144: 123-127.
8. Angelucci, L., M.T. Ramacci, G. Taglialatela, et al. 1988. Nerve growth factor binding in aged rat central nervous system: effect of acetyl-L-carnitine. J. Neurosci. Res. 20: 491-496.
9. Bertoni-Freddari, C., P. Fattoretti, T. Casoli, et al. 1994. Dynamic morphology of the synaptic junctional areas during aging: the effect of chronic acetyl-L-carnitine administration. Brain Res. 656: 359-366.
10. Bertoni-Freddari, C., P. Fattoretti, U. Caselli, et al. 1996. Acetylcarnitine modulation of the morphology of rat hippocampal synapses. Anal. Quant. Cytol. Histol. 18: 275-278.
11. Spagnoli, A., U. Lucca, G. Menasce, et al. 1991. Longtermacetyl-L- carnitine treatment inAlzheimer's disease. Neurology 41: 1726-1732.
12. Rosenthal, R.E., R. Williams, Y.E. Bogaert, et al. 1992. Prevention of postischemic canine neurological injury through potentiation of brain energy metabolism by acetyl-L-carnitine. Stroke 23: 1312-1317; discussion 1317-1318.
13. Sima, A.A., H. Ristic, A.Merry, et al. 1996. Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat. J. Clin. Invest. 97: 1900-1907.
14. Zanelli, S.A., N.J. Solenski, R.E. Rosenthal, et al. 2005. Mechanisms of ischemic neuroprotection by acetyl-Lcarnitine. Ann. N.Y. Acad. Sci. 1053: 153-161.
15. Shuaib, A., T. Waqaar, T. Wishart, et al. 1995. Acetyl-L-carnitine attenuates neuronal damage in gerbils with transient forebrain ischemia only when given before the insult. Neurochem. Res. 20: 1021-1025.
16. Chen, S.T., C.Y. Hsu, E.L. Hogan, et al. 1986. Amodel of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke 17: 738-743.
17. Tamura, A., D.I. Graham, J. McCulloch, et al. 1981. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1: 53-60. (Pubitemid 12230166)
18. Longa, E.Z., P.R. Weinstein, S. Carlson, et al. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91.
19. Paxinos, G. & C.Watson. 1982. The Rat Brain in Stereotaxic Coordinates. Academic Press. Sydney, Australia.
20. Karlsson, G.A., K.A. Chaitoff, S. Hossain, et al. 2007. Modulation of cardiovascular responses and neurotransmission during peripheral nociception following nNOS antagonism within the periaqueductal gray. Brain Res. 1143: 150-160.
21. Durukan, A. & T. Tatlisumak. 2007. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol. Biochem. Behav. 87: 179-197.
22. Lolic, M.M., G. Fiskum & R.E. Rosenthal. 1997. Neuroprotective effects of acetyl-L-carnitine after stroke in rats. Ann. Emerg. Med. 29: 758-765.
23. Carmichael, S.T. 2005. Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2: 396-409.
24. Turski, L., H.H. Schneider, R.Neuhaus, et al. 2000. Phosphonate quinoxalinedione AMPA antagonists. Restor. Neurol. Neurosci. 17: 45-59.
25. Takagi, K., M.D. Ginsberg, M.Y. Globus, et al. 1993. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopathology. J.Cereb. Blood FlowMetab. 13: 575-585.
26. Erdo, F., P. Berzsenyi & F. Andrasi. 2005. The AMPAantagonist talampanel is neuroprotective in rodentmodels of focal cerebral ischemia. Brain Res. Bull. 66: 43-49.
27. Garcia, J.H., K.F. Liu & K.L.Ho. 1995.Neuronal necrosis after middle cerebral artery occlusion inWistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke 26: 636-642; discussion 643.
28. Melani, A., L. Pantoni, C. Corsi, et al. 1999. Striatal outflow of adenosine, excitatory amino acids, gammaaminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage. Stroke 30: 2448-2454; discussion 2455.
29. Garcia, J.H., S. Wagner, K.F. Liu, et al. 1995. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 26: 627-634; discussion 635.
30. Saleh, T.M., B.J. Connell, C. Legge, et al. 2004. Estrogen attenuates neuronal excitability in the insular cortex following middle cerebral artery occlusion. Brain Res. 1018: 119-129.
31. Katayama, Y., T. Kawamata, T. Tamura, et al. 1991. Calcium-dependent glutamate release concomitant with massive potassium flux during cerebral ischemia in vivo. Brain Res. 558: 136-140.
32. Seki, Y., P.J. Feustel, R.W.Keller, Jr., et al. 1999. Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokinate and an anion channel blocker. Stroke 30: 433-440.
33. Phillis, J.W., J. Ren & M.H. O'Regan. 2000. Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studieswithDL-threo-betabenzyloxyaspartate. Brain Res. 868: 105-112.
34. Camacho, A.&L.Massieu. 2006.Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death. Arch. Med. Res. 37: 11-18.
35. Rossi, D.J., T. Oshima & D. Attwell. 2000. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403: 316-321.
36. Drejer, J., H. Benveniste, N.H. Diemer, et al. 1985. Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro. J. Neurochem. 45: 145-151.
37. Goldberg, W.J., R.M. Kadingo & J.N. Barrett. 1986. Effects of ischemia-like conditions on cultured neurons: protection by low Na+, lowCa2+ solutions. J. Neurosci. 6: 3144-3151.
38. Swanson, R.A. 1992. Astrocyte glutamate uptake during chemical hypoxia in vitro. Neurosci. Lett. 147: 143-146.
39. Rothstein, J.D., M. Dykes-Hoberg, C.A. Pardo, et al. 1996. Knockout of glutamate transporters reveals a major role for astroglial transport inexcitotoxicity andclearance of glutamate. Neuron 16: 675-686.
40. Dronne, M.A., E. Grenier, T. Dumont, et al. 2007. Role of astrocytes in grey matter during stroke: a modelling approach. Brain Res. 1138: 231-242.
41. Longuemare, M.C. & R.A. Swanson. 1995. Excitatory amino acid release from astrocytes during energy failure by reversal of sodium-dependent uptake. J.Neurosci. Res. 40: 379-386.
42. Rothstein, J.D., S. Patel, M.R. Regan, et al. 2005. Betalactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433: 73-77.
43. Chu, K., S.T. Lee, D.I. Sinn, et al. 2007. Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation. Stroke 38: 177-182.
44. Rao, K.V. & I.A. Qureshi. 1999. Reduction in the MK-801 binding sites of the NMDA sub-type of glutamate receptor in amouse model of congenital hyperammonemia: prevention by acetyl-L-carnitine. Neuropharmacology 38: 383-394.
45. Forloni, G., N. Angeretti & S. Smiroldo. 1994. Neuroprotective activity of acetyl-L-carnitine: studies in vitro. J. Neurosci. Res. 37: 92-96.
46. Peters, O., T. Back, U. Lindauer, et al. 1998. Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 18: 196-205.
47. Trotti, D., N.C. Danbolt & A. Volterra. 1998. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol. Sci. 19: 328-334.
48. Rao, S.D.,H.Z. Yin&J.H.Weiss. 2003. Disruption of glial glutamate transport by reactive oxygen species produced in motor neurons. J. Neurosci. 23: 2627-2633.
49. Fariello, R.G., T.N. Ferraro, G.T. Golden, et al. 1988. Systemic acetyl-L-carnitine elevates nigral levels of glutathione and GABA. Life Sci. 43: 289-292.
50. Bogaert, Y.E., K.F. Sheu, P.R. Hof, et al. 2000. Neuronal subclass-selective loss of pyruvate dehydrogenase immunoreactivity following canine cardiac arrest and resuscitation. Exp. Neurol. 161: 115-126.
51. Liu, Y., R.E. Rosenthal, P. Starke-Reed, et al. 1993. Inhibition of postcardiac arrest brain protein oxidation by acetyl-L-carnitine. Free Radic. Biol. Med. 15: 667-670.
52. Rosenthal,R.E., Y.E. Bogaert&G. Fiskum. 2005. Delayed therapy of experimental global cerebral ischemia with acetyl-L-carnitine in dogs. Neurosci. Lett. 378: 82-87.